Pharmaceutical Substances Syntheses, Patents, Applications - Part 190

Pharmaceutical Substances Syntheses, Patents, Applications - Part 190. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers. | spiperone s 1891 Formulation s vial 3 g as dihydrochloride pentahydrate Trade Name s D Stanilo Pharmacia Upjohn F Trobicine Pharmacia Upjohn GB Trobicin Pharmacia Upjohn 1 Trobicin Pharmacia Upjohn J Trobicin Nihon Upjohn USA Trobicin Upjohn wfm Spiperone ATC N05C Use neuroleptic RN 749-02-0 MF C23H26FN3O2 MW E1NECS 212-024-0 LD50 mg kg M . 600 mg kg M . 14 mg kg R . 1 g kg R . 20 mg kg dog . 100 mg kg dog p 0. CN 8- 4- 4-fluorophenyl -4-oxobutyl -l-phenyl-l 3 8-triazaspiro decan-4-one 4-chloro-4 -fluoro- butyrophenone cf. holoperidol synthesis 4-axo-1-phenyl-1 3 8-tñazaspíro- decane cf. fluspirilene synthesis Reference s US 3 155 669 Janssen appl. . US 3 155 670 Janssen appl. . US 3 161 644 Janssen appl. . Formulation s tabl. mg vial 3 mg Trade Name s J spiropitan Eisai Spiramycin ATC J01FA02 Use antibiotic RN 8025-81-8 MF unspecified MW unspecified EINECS 232-429-6 LD50 130mg kg M . 2900 mg kg M . 170mg kg R . 3550 mg kg R . 5200 mg kg dog . CN spiramycin 1892 S Spirapril Spiramycin 1 Spiramycin 11 Spiramycin Ill From culture of Streptomyces ambofaciens. Reference s US 2 943 023 Rhöne-Poulenc F-prior. . US 2 978 380 Rhöne-Poulenc F-prior. . US 3 000 785 Rhöne-Poulenc F-prior. . US 3 011 947 Rhöne-Poulenc F-prior. . Pinnert-Sindico S. et al. Antibiot. Annu. ABANAE 1954-1955 724. Formulation s f. c. tabl. mg 250 mg 375 mg 500 mg Trade Name s D Rovamycine Rhöne- Poulenc Rorer Selectomycin Grünenthal F Rodogyl Specia -comb. Rovamycine Specia GB Rovamycin May Baker wfm I Rovamicina Rhöne- Poulenc Rorer Spirapril Sch-33844 ATC C09AA11 Use antihypertensive ACE inhibitor RN 83647-97-6 MF C22H30N2O5S2 MW LD5 2500 mg kg M . 2500 mg kg R . CN 8S- 7 R R 8R -7- 2- l- ethoxycarbonyl -3-phenylpropyl amino -l-oxopropyl -l 4-dithia-7-azaspiro nonane-8-carboxylic .

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU MỚI ĐĂNG
187    24    1    27-11-2024
463    20    1    27-11-2024
15    16    4    27-11-2024
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.